OpenVSafe by OpenVAERS
Search V-safe

UTR-28323-06288

3 vaccinations 3 coded responses 13 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
152 / PA
Registered
2021-02-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-28
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-17
    Registered in v-safe
  3. 2021-02-17
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-02-18
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-02-19
    Dose 2 — Pfizer-BioNTech
  6. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches
    Adult check-in
  7. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-02-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-03-01
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-03-19
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-22
    Survey response — 3 months, dose 2
    MedDRA: Cholelithiasis, Gallbladder disorder, Gallbladder operation — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Gallbladder issues, gall stones, surgery to remove gallbladder.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-22
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-10-16
    Dose 3 — Pfizer-BioNTech
  16. 2022-02-14
  17. 2022-02-19
    Survey response — 12 months, dose 2
    MedDRA: Pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Pregnancy. Currently 30 weeks along.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-02-19
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  19. 2022-02-21
  20. 2022-04-23
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  21. 2022-10-16
    Survey response — 12 months, dose 3
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: COVID-19
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-10-16
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  23. 2022-10-18
  24. 2022-10-18
  25. 2022-10-18

Vaccinations

DoseDateManufacturerCo-administered
12021-01-28Pfizer-BioNTech
22021-02-19Pfizer-BioNTech
32021-10-16Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-05-22 Unsuccessful
2022-02-19 Unsuccessful
2022-10-16 Unsuccessful

Free text

Release 8 — 3 months, dose 2

2021-05-22

Symptoms: Gallbladder issues, gall stones, surgery to remove gallbladder.

Release 11 — 12 months, dose 2

2022-02-19

Symptoms: Pregnancy. Currently 30 weeks along.

Release 12 — 12 months, dose 3

2022-10-16

Symptoms: COVID-19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCholelithiasis ✓ ✓ ✓
SDCOVID-19 · · ✓
SDGallbladder disorder ✓ ✓ ✓
SDGallbladder operation ✓ ✓ ✓
SDPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…